Please use this identifier to cite or link to this item:
Title: Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer
Authors: Xie, J. 
Lei, C.
Hu, Y.
Gay, G.K.
Jamali, N.H.B.
Wang, C.-H. 
Keywords: Blood-brain barrier
Cancer chemotherapy
Issue Date: 2010
Citation: Xie, J., Lei, C., Hu, Y., Gay, G.K., Jamali, N.H.B., Wang, C.-H. (2010). Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer. Current Pharmaceutical Design 16 (21) : 2331-2340. ScholarBank@NUS Repository.
Abstract: Paclitaxel appears to be a potential substrate of the multidrug resistance protein p-glycoprotein, thus preventing itself from entry into the brain and penetrating blood-brain barrier poorly. In this study, the main objective was to design paclitaxel formulation using PLGA-based nanoparticles with different additives and surface coatings to facilitate the paclitaxel transport through MDCK cell monolayer. PLGA-based nanoparticles of around 200 nm without and with additives and surface coatings were developed by direct dialysis. The transendothelial electrical resistance (TEER) variation of MDCK cell monolayer on the cell inserts imposed by paclitaxel-loaded nanoparticles with and without additives was investigated. (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) (MTT) assay was used to quantify the cell viability of C6 glioma cells after administration of formulations on the topical side. Investigations showed that particles with additives were able to enhance cellular uptake more than surface-coated particles. TEER values dropped upon the introduction of paclitaxel-loaded PLGA nanoparticles to the cell inserts. After incubation for 24 h, the cell viability of C6 glioma cells in the wells treated with nanoparticles was lower than that of the control wells without particles. Taken together, PLGA nanoparticles with vitamin E TPGS and polysorbate 80 as additives were successfully obtained as paclitaxel formulations, demonstrating great potential for the delivery of paclitaxel through MDCK cell monolayer in vitro. © 2010 Bentham Science Publishers Ltd.
Source Title: Current Pharmaceutical Design
ISSN: 13816128
DOI: 10.2174/138161210791920432
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jan 21, 2021


checked on Jan 21, 2021

Page view(s)

checked on Jan 18, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.